Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Loading phase protocol (acute injury or initial treatment): Dose: 500 mcg to 1 mg per injection Frequency: Once daily Duration: 7 to 10 days Injection site: Subcutaneous, ideally near the area of concern Timing: Morning or evening, consistency matters more than specific time Maintenance phase protocol: Dose: 500 mcg to 1 mg per injection Frequency: 2 to 3 times per week Duration: 4 to 8 weeks total protocol length Cycle recommendation: 2 months on, 2 months off Unlike traditional BPC-157 acetate, which is often administered twice daily due to its shorter half-life, the enhanced stability of the arginate form typically allows for once-daily dosing during the loading phase
An error at any step cascades through the rest
The best peptide is the one that matches your primary objective
29.50 - BPC-157 - Research Peptide At New Wave Peptides, our BPC-157 is a specialised research-grade peptide engineered for advanced laboratory investigation, particularly in the field of tissue study and regenerative science
Beneficial Effects of BPC-157 in Other Systems In another study, BPC-157 was suggested to have protective effects following traumatic brain injury in rats
US$ 27.61
US$ 22.68
US$ 23.04
US$ 22.61
